AUPR178300A0 - Cyclodextrins and reversal of atherosclerosis - Google Patents

Cyclodextrins and reversal of atherosclerosis

Info

Publication number
AUPR178300A0
AUPR178300A0 AUPR1783A AUPR178300A AUPR178300A0 AU PR178300 A0 AUPR178300 A0 AU PR178300A0 AU PR1783 A AUPR1783 A AU PR1783A AU PR178300 A AUPR178300 A AU PR178300A AU PR178300 A0 AUPR178300 A0 AU PR178300A0
Authority
AU
Australia
Prior art keywords
cyclodextrins
atherosclerosis
reversal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR1783A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heart Research Institute Ltd
Original Assignee
Heart Research Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heart Research Institute Ltd filed Critical Heart Research Institute Ltd
Priority to AUPR1783A priority Critical patent/AUPR178300A0/en
Publication of AUPR178300A0 publication Critical patent/AUPR178300A0/en
Priority to AU2002223303A priority patent/AU2002223303A1/en
Priority to PCT/AU2001/001547 priority patent/WO2002043742A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AUPR1783A 2000-11-29 2000-11-29 Cyclodextrins and reversal of atherosclerosis Abandoned AUPR178300A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPR1783A AUPR178300A0 (en) 2000-11-29 2000-11-29 Cyclodextrins and reversal of atherosclerosis
AU2002223303A AU2002223303A1 (en) 2000-11-29 2001-11-29 Cyclodextrins and reversal of atherosclerosis
PCT/AU2001/001547 WO2002043742A1 (en) 2000-11-29 2001-11-29 Cyclodextrins and reversal of atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR1783A AUPR178300A0 (en) 2000-11-29 2000-11-29 Cyclodextrins and reversal of atherosclerosis

Publications (1)

Publication Number Publication Date
AUPR178300A0 true AUPR178300A0 (en) 2000-12-21

Family

ID=3825820

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPR1783A Abandoned AUPR178300A0 (en) 2000-11-29 2000-11-29 Cyclodextrins and reversal of atherosclerosis
AU2002223303A Abandoned AU2002223303A1 (en) 2000-11-29 2001-11-29 Cyclodextrins and reversal of atherosclerosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002223303A Abandoned AU2002223303A1 (en) 2000-11-29 2001-11-29 Cyclodextrins and reversal of atherosclerosis

Country Status (2)

Country Link
AU (2) AUPR178300A0 (en)
WO (1) WO2002043742A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291590B2 (en) * 2003-06-12 2007-11-06 Queen's University At Kingston Compositions and methods for treating atherosclerosis
WO2007119103A1 (en) * 2005-10-17 2007-10-25 Robert Bender Labeled macrophages and methods of use thereof
US7674772B2 (en) 2006-03-31 2010-03-09 Queen's University At Kingston Compositions and methods for treating atherosclerosis
CN101448486B (en) * 2006-05-19 2012-10-31 凡罗布洛克公司 A composition for inactivating an enveloped virus
FR3014694B1 (en) * 2013-12-13 2016-11-11 Roquette Freres METHYL-CYCLODEXTRIN-BASED COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES BY INCREASING THE CHOLESTEROL-HDL RATE
WO2020142716A1 (en) 2019-01-03 2020-07-09 Sens Research Foundation, Inc. Cyclodextrin dimers, compositions thereof, and uses thereof

Also Published As

Publication number Publication date
WO2002043742A1 (en) 2002-06-06
WO2002043742A8 (en) 2002-09-12
AU2002223303A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
AU2001231183A1 (en) Consolidation and reduction of usage data
WO2002017157A8 (en) Marketing systems and methods
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001234581A1 (en) Connected audio and other media objects
AU2001296535A1 (en) High performance nanostructured materials and methods of making the same
AU2002230484A1 (en) System and method of managing documents
AU2001269331A1 (en) Cleaning and doping of tubulars
AU2001244916A1 (en) Processing of documents
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2002235252A1 (en) Deblurring and re-blurring image segments
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2001238652A1 (en) Turning-wave amplitude inversion
AU2002211717A1 (en) Stresscopins and their uses
AUPP986099A0 (en) Water repellent compositions methods and applications therefor
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001267171A1 (en) Modified xylanases exhibiting increased thermophilicity and alkalophilicity
AU2002230717A1 (en) Use of convergence-enabled dvd and web system
AU2001272798A1 (en) Method of reformatting web page and method of providing web page using the same
AUPR178300A0 (en) Cyclodextrins and reversal of atherosclerosis
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AUPQ872300A0 (en) Compounds and methods

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 2330302

Country of ref document: AU